-
公开(公告)号：US20240189381A1
公开(公告)日：2024-06-13
申请号：US18518089
申请日：2023-11-22
发明人： Xuhong JIANG , Senlin SHI , Jingbo XU , Shanshan LU , Lingtian WENG , Yuqin LOU
IPC分类号： A61K36/718 , A61K35/64 , A61K36/284 , A61K36/428 , A61K36/537 , A61K36/734 , A61K36/808 , A61K36/899 , A61P3/10
CPC分类号： A61K36/718 , A61K35/64 , A61K36/284 , A61K36/428 , A61K36/537 , A61K36/734 , A61K36/808 , A61K36/899 , A61P3/10 , A61K2236/15 , A61K2236/17 , A61K2236/39
摘要： The present disclosure provides a traditional Chinese medicine (TCM) composition for preventing and treating diabetes, a TCM preparation and use thereof, and belongs to the technical field of medicine. The TCM composition includes the following raw materials: 3-20 parts by weight of Rhizoma Coptidis, 9-24 parts by weight of Rhizoma Atractylodis, 6-24 parts by weight of Feculae Bombycis, 10-60 parts by weight of Stigma Maydis, 10-60 parts by weight of Radix Trichosanthis, 6-30 parts by weight of Radix Scrophulariae, 10-60 parts by weight of Radix et Rhizoma Salviae Miltiorrhizae, and 10-50 parts by weight of Fructus Crataegi Preparata. In the TCM composition provided by the present disclosure, all medicinal materials are synergistic to achieve the effects of clearing heat, drying dampness, fortifying the spleen, dispersing blood stasis, dispersing accumulations, lowering lipids, nourishing yin and moistening dryness.
-
公开(公告)号：US20180161387A1
公开(公告)日：2018-06-14
申请号：US15889921
申请日：2018-02-06
发明人： Tomy YESUDAS , Philip ALEX , Michael CENTOLA , Adam Joshua PAYNE
IPC分类号： A61K36/90 , A61K36/77 , A61K36/27 , A61K36/28 , A61K36/48 , A61K36/29 , A61K36/76 , A61K36/31 , A61K36/899 , A61K36/71 , A61K36/22 , A61K36/185 , A61K36/23 , A61K36/68 , A61K36/66 , A61K36/24 , A61K36/35 , A61K36/808
CPC分类号： A61K36/90 , A61K36/185 , A61K36/22 , A61K36/23 , A61K36/24 , A61K36/27 , A61K36/28 , A61K36/29 , A61K36/31 , A61K36/35 , A61K36/48 , A61K36/66 , A61K36/68 , A61K36/71 , A61K36/76 , A61K36/77 , A61K36/808 , A61K36/899 , A61K2300/00
摘要： Disclosed herein are herbal formulations for relief from symptoms of skin disease. The formulations can also be combined with an active or inactive pharmaceutical ingredient, and/or a pharmaceutically acceptable excipient.
-
公开(公告)号：US20160151278A1
公开(公告)日：2016-06-02
申请号：US14992968
申请日：2016-01-11
申请人： Try This First, Inc.
发明人： Scott MOREHOUSE
IPC分类号： A61K9/00 , A61K31/616 , A61K31/167 , A23G3/56 , A61K45/06 , A61K36/752 , A61K31/7032 , A61K31/194 , A61K31/047 , A61K31/375 , A61K31/192 , A61B17/24
CPC分类号： A61K9/0056 , A23G3/563 , A61B17/24 , A61K31/045 , A61K31/047 , A61K31/07 , A61K31/167 , A61K31/19 , A61K31/192 , A61K31/194 , A61K31/197 , A61K31/355 , A61K31/375 , A61K31/4188 , A61K31/4415 , A61K31/455 , A61K31/51 , A61K31/519 , A61K31/525 , A61K31/616 , A61K31/675 , A61K31/7032 , A61K33/00 , A61K33/06 , A61K36/00 , A61K36/28 , A61K36/48 , A61K36/534 , A61K36/63 , A61K36/71 , A61K36/752 , A61K36/808 , A61K45/06 , A61K2300/00
摘要： The present invention relates generally to apparatuses and methods for treating ear infections and clearing excess fluid from Eustachian tubes.
摘要翻译： 本发明一般涉及用于治疗耳朵感染并从咽鼓管清除多余液体的装置和方法。
-
公开(公告)号：US20140205685A1
公开(公告)日：2014-07-24
申请号：US14094535
申请日：2013-12-02
申请人： Sirbal, Ltd.
发明人： Nadav Shraibom
IPC分类号： A61K36/708 , A61K36/64 , A61K36/355 , A61K36/65 , A61K36/54 , A61K36/30 , A61K36/808 , A61K33/06 , A61K36/286 , A61K36/315 , A61K36/00 , A61K36/35
CPC分类号： A61K36/815 , A61K9/0014 , A61K31/05 , A61K31/122 , A61K31/185 , A61K31/192 , A61K31/575 , A61K31/7034 , A61K31/7048 , A61K33/06 , A61K36/00 , A61K36/286 , A61K36/30 , A61K36/315 , A61K36/35 , A61K36/355 , A61K36/36 , A61K36/53 , A61K36/54 , A61K36/64 , A61K36/65 , A61K36/708 , A61K36/73 , A61K36/77 , A61K36/804 , A61K36/808 , A61K45/06 , A61K2300/00
摘要： A method and medicine for treating melanoma, BCC (basal cell carcinoma) or psoriasis or other inflammatory skin disease, or a combination thereof, comprising applying or injecting to an infected skin area of a patient diagnosed with melanoma, BCC (basal cell carcinoma) or psoriasis or other inflammatory skin disease, or a combination thereof, a treatment regimen that includes periodic doses of a molecular combination of emodin and digoxin and/or an herbal combination of Da Huang and Sheng Di Huang.
摘要翻译： 一种用于治疗黑素瘤，BCC（基底细胞癌）或牛皮癣或其它炎性皮肤病或其组合的方法和药物，包括向被诊断患有黑素瘤，BCC（基底细胞癌）的患者的感染皮肤区域或 牛皮癣或其它炎症性皮肤疾病或其组合，包括大黄素和地高辛的分子组合的周期性剂量和/或大黄和盛迪黄的草药组合的治疗方案。
-
5.发明申请COMPOSITION FOR PREVENTING OR TREATING ATOPIC DERMATITIS INCLUDING GALENICAL EXTRACT OR LACTOBACILLUS FERMENTATION THEREOF 有权用于预防或治疗特发性皮炎的组合物，包括胃肠道提取物或其乳酸杆菌发酵公开(公告)号：US20130224181A1
公开(公告)日：2013-08-29
申请号：US13825839
申请日：2010-10-29
申请人： Jin Yeul Ma , Tae Ho Chung , Ga Young Im , Dong Seon Kim , Young Ran Um , Hyun Ae Eum , Jae Hoon Lee , Sung Up Choi , Byoung Heon Cho
发明人： Jin Yeul Ma , Tae Ho Chung , Ga Young Im , Dong Seon Kim , Young Ran Um , Hyun Ae Eum , Jae Hoon Lee , Sung Up Choi , Byoung Heon Cho
IPC分类号： A61K36/258 , A61K36/355 , A61K36/232 , A61K36/25 , A61K36/28 , A23L1/30 , A61K36/78 , A61K36/634 , A61K36/296 , A61K36/23 , A61K36/808 , A61K36/489 , A61K36/484 , A61K36/725
CPC分类号： A61K36/258 , A23L33/105 , A61K8/97 , A61K36/23 , A61K36/232 , A61K36/238 , A61K36/25 , A61K36/28 , A61K36/296 , A61K36/355 , A61K36/484 , A61K36/489 , A61K36/634 , A61K36/725 , A61K36/78 , A61K36/808 , A61K2800/85 , A61Q19/00 , A61K2300/00
摘要： The present invention relates to a pharmaceutical composition and health supplement for preventing or treating atopic dermatitis, the composition and supplement having as active ingredients extract of a galenical mixture including sophora root, licorice, lonicer aflower, Korean angelica root, Korean aralia root, saussurea root, seselos radix, zizyphus spinosi, Houttuynia cordata, forsythia fruit, lappa fruit, Epimedium koreanum Nakai, ginseng, lithospermum, oleoresin, cnidium, scorophulariae radix, and reynoutria, or lactobacillus fermentation of the galenical extract prepared by inoculating lactobacillus to the galenical extract and fermenting same. The galenical extract or the galenical extract fermentation of the present invention achieves reduced scratching, decreases clinical features of atopic symptoms such as erythema, itchiness and dry skin, edema and hematoma, erosion, and lichenification, and reduces IgE concentration in blood, which is related to exogenous atopic dermatitis, in laboratory animal models of atopic dermatitis, and is thereby, useful for preventing or treating atopic dermatitis.
摘要翻译： 本发明涉及用于预防或治疗特应性皮炎的药物组合物和健康补充剂，所述组合物和补充剂具有作为活性成分的包含槐根，甘草，椴树叶，韩国当归，韩国檀香根，沙司根 ，莴苣，枸杞子，鱼腥草，连翘果，a果，韩国淫羊藿，人参，lithospermum，油树脂，cnidium，scorophularia根和reynoutria，或乳酸杆菌发酵通过将乳杆菌接种到盖仑液提取物而制备的; 发酵相同。 本发明的盖仑液提取物或盖仑液提取物发酵减少了刮擦，降低了特应性症状如红斑，瘙痒和皮肤干燥，水肿和血肿，侵蚀和苔藓样病变的临床特征，并降低血液中的IgE浓度，这是相关的 对特应性皮炎的实验动物模型中的外源性特应性皮炎，因此可用于预防或治疗特应性皮炎。
-
6.发明申请Pharmaceutical composition for treating parotid gland tumor, cerebroma and renal cyst 审中-公开用于治疗腮腺肿瘤，脑血管和肾囊肿的药物组合物公开(公告)号：US20080279970A1
公开(公告)日：2008-11-13
申请号：US11705220
申请日：2007-05-11
申请人： Jian Zhang
发明人： Jian Zhang
IPC分类号： A61K36/536 , A61K36/808 , A61P35/00 , A61P43/00
CPC分类号： A61K36/536 , A61K36/808
摘要： A Chinese herb pharmaceutical composition for treating tumor is disclosed, wherein the composition is prepared by a predetermined amount of Common Selfheal, and a predetermined amount of Radixscrophulariae.
摘要翻译： 公开了一种用于治疗肿瘤的中草药药物组合物，其中组合物通过预定量的普通自愈和预定量的根尖细胞制备。
-
7.发明授权Pharmaceutical composition having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same 失效对拉米夫定相关疾病复发和耐药性具有预防效果的药物组合物及其使用方法公开(公告)号：US06855346B2
公开(公告)日：2005-02-15
申请号：US10192147
申请日：2002-07-11
申请人： Tzu-Sheng Wu
发明人： Tzu-Sheng Wu
IPC分类号： A61K31/7068 , A61K35/37 , A61K35/413 , A61K36/232 , A61K36/258 , A61K36/481 , A61K36/538 , A61K36/539 , A61K36/59 , A61K36/70 , A61K36/704 , A61K36/734 , A61K36/748 , A61K36/79 , A61K36/808 , A61K36/815 , A61K36/9066 , A61K35/78
CPC分类号： A61K36/79 , A61K31/7068 , A61K35/413 , A61K36/232 , A61K36/258 , A61K36/481 , A61K36/538 , A61K36/539 , A61K36/59 , A61K36/70 , A61K36/704 , A61K36/734 , A61K36/748 , A61K36/808 , A61K36/815 , A61K36/9066 , A61K2300/00
摘要： The present invention provides a method for treating patients with liver diseases by co-administrating a pharmaceutical composition and lamivudine to the patients. The pharmaceutical composition is a herbal mixture which contains, as the core ingredients, the aqueous extracts of the entire plant of Herba Hedyotidis diffusae, the rhizome of Rhizoma Bistortae, the rhizome of Rhizoma Polygoni Cuspidati, and the ripe fruit of Fructus Schisandrae. The present invention also provides methods for preventing a relapse of hepatitis in patients after the lamivudine treatment has been discontinued and for suppressing the development of lamivudine drug resistance in patients by providing the lamivudine-treated patients with the pharmaceutical composition of the present invention.
摘要翻译： 本发明提供了通过将药物组合物和拉米夫定共同施用给患者来治疗肝病患者的方法。 药物组合物是含有作为核心成分的草本禾本科植物的全部植物的水提取物，双孢杆菌根茎，黄芪根茎和五味子成熟果实的草药混合物。 本发明还提供了在拉米夫定治疗已经中止之后预防患者中的肝炎复发并且通过向拉米夫定治疗的患者提供本发明的药物组合物来抑制患者中拉米夫定耐药性发展的方法。
-
8.发明申请公开(公告)号：US20030091658A1
公开(公告)日：2003-05-15
申请号：US10208050
申请日：2002-07-31
发明人： Tzu-Sheng Wu
IPC分类号： A61K035/78 , A61K035/12 , A61K035/37
CPC分类号： A61K36/185 , A61K36/232 , A61K36/258 , A61K36/481 , A61K36/535 , A61K36/539 , A61K36/59 , A61K36/70 , A61K36/704 , A61K36/734 , A61K36/748 , A61K36/79 , A61K36/808 , A61K36/815 , A61K36/9066 , A61K2300/00
摘要： The present invention provides a pharmaceutical composition for treating patients with HIV infection. The pharmaceutical composition is in the form of an intravenous injection solution and optionally capsules. The pharmaceutical composition contains fourteen (14) ingredients, i.e., diffuse hedyotis, bistort rhizome, giant knotweed rhizome, Asiatic moonseed rhizome, baical skullcap root, bovine biliary powder, milkvetch root, barbary wolfberry fruit, sanqi, figwort root, Chinese magnoliavine fruit, turmeric root-tuber, hawthorn fruit, and Chinese angelica.
摘要翻译： 本发明提供了用于治疗HIV感染患者的药物组合物。 药物组合物是静脉注射溶液和任选的胶囊形式。 药物组合物含有十四（14）种成分，分别是扩散性水蛭，ort根，巨eed根，亚洲ed根，黄芩，牛胆，牛蒡根，枸杞子，三旗，玄参， 姜黄根茎，山楂果和当归。
-
公开(公告)号：US20240335496A1
公开(公告)日：2024-10-10
申请号：US18421911
申请日：2024-01-24
发明人： Lei XIAO , Lingling HE , Jinlian HUANG , Yan GAO
IPC分类号： A61K36/718 , A61K9/00 , A61K9/06 , A61K36/28 , A61K36/346 , A61K36/42 , A61K36/484 , A61K36/53 , A61K36/539 , A61K36/725 , A61K36/752 , A61K36/808 , A61K36/88 , A61K36/9068 , A61K47/10 , A61K47/26 , A61K47/38 , A61P1/04
CPC分类号： A61K36/718 , A61K9/006 , A61K9/06 , A61K36/28 , A61K36/346 , A61K36/42 , A61K36/484 , A61K36/53 , A61K36/539 , A61K36/725 , A61K36/752 , A61K36/808 , A61K36/88 , A61K36/9068 , A61K47/10 , A61K47/26 , A61K47/38 , A61P1/04 , A61K2236/15 , A61K2236/53
摘要： The present invention is related to a modified prescription of Gancao Xiexin decoction and the use thereof. The modified prescription of Gancao Xiexin decoction of the present invention mainly contains Coptidis Rhizoma, Scutellariae Radix, Glycyrrhizae Radix et Rhizoma, Zingiberis Rhizoma, Jujubae Fructus, Citri Reticulatae Pericarpium and Bolbostemmatis Rhizoma with effects of alleviating inflammatory reaction and promoting oral healing, and can be used for treating oral ulcer or for preparing a product for treating oral ulcer, which helps reduce the recurrence of oral ulcer. Meanwhile, the present invention also provides a soft gel containing the aqueous extract of the modified prescription of Gancao Xiexin decoction, which has a simple composition, does not contain toxic traditional Chinese medicine, can be administered by coating oral ulcer, is convenient to use and has a good therapeutic effect.
-
公开(公告)号：US20240285721A1
公开(公告)日：2024-08-29
申请号：US18659701
申请日：2024-05-09
发明人： Tomy YESUDAS , Philip ALEX , Michael CENTOLA , Adam Joshua PAYNE
IPC分类号： A61K36/90 , A61K36/185 , A61K36/22 , A61K36/23 , A61K36/24 , A61K36/27 , A61K36/28 , A61K36/29 , A61K36/31 , A61K36/35 , A61K36/48 , A61K36/66 , A61K36/68 , A61K36/71 , A61K36/76 , A61K36/77 , A61K36/808 , A61K36/899
CPC分类号： A61K36/90 , A61K36/185 , A61K36/22 , A61K36/23 , A61K36/24 , A61K36/27 , A61K36/28 , A61K36/29 , A61K36/31 , A61K36/35 , A61K36/48 , A61K36/66 , A61K36/68 , A61K36/71 , A61K36/76 , A61K36/77 , A61K36/808 , A61K36/899
摘要： Disclosed herein are herbal formulations for relief from symptoms of skin disease. The formulations can also be combined with an active or inactive pharmaceutical ingredient, and/or a pharmaceutically acceptable excipient.
-
-
-
-
-
-
-
-
-
搜索结果
35 条记录 (耗时 0.02 秒)
